Keywords
quality of life
heart failure
How to Cite
Abstract
Background. Chronic diseases, which include heart failure can have symptoms similar to the symptoms of the anxiety and depression. The presence of depressive symptoms is associated with mortality, quality of life and health of patients with HF, regardless of the clinical parameters. Unfortunately, depressive symptoms occur in people with heart failure more frequently than in general population. Objectives. To evaluate anxiety and depression on quality of patients with heart failure. Material and methods. The study was conducted among 58 patients (41 men, 17 women), suffering from heart failure located in the Hospital in Kluczbork. The average age of the study group was 65 years. To gather research material were used: socio-demographic survey, Short Form-36 (SF-36), the scale of HADS-M. Considered statistically significant at p < 0.05. Results. The mean overall level of anxiety scale of respondents was M = 8.6 (SD = 4.4). The average overall scale of depression was M = 6.5 (SD = 4.6). The average overall level of anxiety scale was M = 3.1 (SD = 1.7). Correlation analysis showed that the patients who had higher levels of anxiety (HADS-M) had a lower level of physical activity, pain, general health perception, vitality, social functioning, mental health, activity limitations due to emotional problems and a lower level of physical and mental summary score. Conclusions. A high rate of anxiety and depression reduces the quality of life of patients with heart failure.References
Massie BM, Shah NB. The heart failure epidemic: Magnitude of the problem and potencial mitigating approaches. Curr Opin Cardiol 1996; 11: 221–226.
Sobański P, Stec S, Opolski G. Niewydolność serca jako cel dla medycyny paliatywnej. Medycyna Paliatywna w Praktyce 2009; 3(2): 69–73.
Krajewska-Kułak E, Sierakowska M, Lewko J, i wsp., red. Pacjent podmiotem troski zespołu terapeutycznego. Białystok: T. 1. Akademia Medyczna Wydział Pielęgniarstwa i Ochrony Zdrowia; 2012: 39–40.
Bilikiewicz A. Psychiatria. Podręcznik dla studentów medycyny. Wyd. 3, Warszawa: Wydawnictwo Lekarskie PZWL; 2006.
Vaccarino V, Kasl SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199–205.
Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849–1856.
Murberg TA, Bru E, Aarsland T, et al. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med 1998; 28: 273–291.
Friedman MM, Griffin JA. Relationship of physical symptoms and physical functioning to depression in patients with heart failure. Heart Lung 2001; 30: 98–104. Wpływ lęku i depresji na jakość życia pacjentów z niewydolnością serca
Havranek EP, Ware M, Lowes BD. Prevalence of depression in patients with congestive heart failure. Am J Cardiol 1999; 84: 348–350.
Koenig H. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998; 20: 29–43.
Skotzko C, Krichten C, Zietowski G, et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail 2000; 6: 300–305.
Jacob S, Sebastian JC, Abraham G. Depression and congestive heart failure. Are antidepressants underutilized? Eur J Heart Fail 2003; 5: 399–400.
Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis and treatment of depression. J Geen Intern Med 1999; 14: 569–580.
Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 2002; 52: 164–174.
Szyguła-Jurkiewicz B, Duszańska A, Poloński L. Czy obecność zaburzeń depresyjnychjestproblememupacjentówzprzewlekłąniewydolnością serca? Polskie Archiwum Medycyny Wewnętrznej 2008; 118: 1–2.
Osmańska M, Borkowska A, Makarewicz R. Ocena jakości życia, nasilenia cech lęku i depresji u pacjentów ze złośliwym zarodkowym nowotworem jądra w trakcie chemioterapii i po zakończonym leczeniu onkologicznym. Psychiatria Polska 2010; XLIV(4): 543–556.
Bekelman B, et al. Clinical Investigation Symptoms, Depression, and Quality of Life in Patients With Heart Failure. Journal of Cardiac Failure 2007; 13(8): 643–648.
Lesman-Leegte I, et al. Clinical Investigations Quality of Life and Depressive Symptoms in the Elderly: A Comparison Between Patients With Heart Failure and Age- and Gender-Matched Community Controls. Journal of Cardiac Failure 2009; 15(1): 17–23.
Rutledge T, et al. Depression in Heart Failure A Meta-Analytic Review of Prevalence, Intervention Effects, and Associations With Clinical Outcomes. Cardiol 2006; 48(8): 1527–1537.
Parissis JT, Venetsanou KF, Mentzikof DG, et al. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure. Scand Cardiovasc J 1999; 33: 344–350.
Hasper D, Hummel M, Kleber FX, et al. Systemic inflammation in patients with heart failure. Eur Heart J 1998; 19: 761–765.
Powell LH, Catellier D, Freedland KE. ENRICHD Investigators Depression and heart failure in patients with a new myocardial infarction. Am Heart J 2005; 149: 851–855.
Richardson LG. Psychosocial issues in patients with congestive heart failure. Prog Cardiovasc Nurs 2003; 18: 19–27.
Dunbar BS, Clark CP, Quinn Ch, et al. Family Influences on Heart Failure Self – care and outcomes. J Cardiovasc Nurs 2008; 23(3): 258–265.